Education
About Us
Working with TipRanks
Follow Us
Lifeward (LFWD)
NASDAQ:LFWD
LFWD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.50 - $4.00
Previous CloseN/A
Volume483.00K
Average Volume (3M)270.54K
Market Cap
$8.84M
Enterprise Value$2.26M
Total Cash (Recent Filing)$5.14M
Total Debt (Recent Filing)$375.00K
Price to Earnings (P/E)―
Beta1.24
Next Earnings
Nov 18, 2025EPS Estimate
-0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares Outstanding15,704,622
10 Day Avg. Volume262,900
30 Day Avg. Volume270,536
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.26
Enterprise Value/Revenue0.09
Enterprise Value/Gross Profit0.26
Enterprise Value/Ebitda-0.14
Forecast
1Y Price Target
$3.00Price Target Upside435.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Bulls Say, Bears Say
Bulls Say
Financial PerformanceLifeward's Q4 results showed a gross margin of 45.4%, ahead of the 41.9% expectation.
Market PenetrationManagement plans to expand market penetration of ReWalk Personal among patients covered by Centers for Medicare & Medicaid Services, workers compensation insurance and US commercial insurers.
PartnershipsRecent developments help diversify Lifeward's business through an exclusive partnership with CorLife and an expanded distribution agreement with MYOLYN.
Bears Say
EarningsThe company reported a net loss of $1.73 per share, compared to consensus estimated net loss of $0.31 per share.
Reimbursement DelaysThe company continues to experience longer than expected time to receive CMS reimbursement.
Revenue GuidanceLifeward's FY2025 revenue guidance was mixed, showing lower revenue than forecasted despite a better bottom line.
Lifeward News
LFWD FAQ
What was Lifeward’s price range in the past 12 months?
Lifeward lowest stock price was $0.50 and its highest was $4.00 in the past 12 months.
What is Lifeward’s market cap?
Lifeward’s market cap is $8.84M.
When is Lifeward’s upcoming earnings report date?
Lifeward’s upcoming earnings report date is Nov 18, 2025 which is in 57 days.
How were Lifeward’s earnings last quarter?
Lifeward released its earnings results on Aug 14, 2025. The company reported -$0.31 earnings per share for the quarter, missing the consensus estimate of -$0.285 by -$0.025.
Is Lifeward overvalued?
According to Wall Street analysts Lifeward’s price is currently Undervalued.
Does Lifeward pay dividends?
Lifeward does not currently pay dividends.
What is Lifeward’s EPS estimate?
Lifeward’s EPS estimate is -0.2.
How many shares outstanding does Lifeward have?
Lifeward has 15,704,622 shares outstanding.
What happened to Lifeward’s price movement after its last earnings report?
Lifeward reported an EPS of -$0.31 in its last earnings report, missing expectations of -$0.285. Following the earnings report the stock price went down -15.278%.
Which hedge fund is a major shareholder of Lifeward?
Currently, no hedge funds are holding shares in LFWD
Company Description
Lifeward
Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.
LFWD Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with significant achievements in product placements and operational efficiencies, particularly in Germany, counterbalanced by revenue decline and a substantial goodwill impairment charge. The company is optimistic about future growth but has adjusted its guidance to reflect current challenges.View all LFWD earnings summariesTechnical Analysis
Ownership Overview
10.66% Insiders
0.02% Mutual Funds
<0.01% Other Institutional Investors
89.32% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---